The anxiolytic effects of cannabidiol (CBD) (2016)
- Authors:
- USP affiliated authors: CAMPOS, ALLINE CRISTINA DE - FMRP ; ZUARDI, ANTONIO WALDO - FMRP ; CRIPPA, JOSÉ ALEXANDRE DE SOUZA - FMRP ; HALLAK, JAIME EDUARDO CECILIO - FMRP ; GUIMARÃES, FRANCISCO SILVEIRA - FMRP
- Unidade: FMRP
- Subjects: CANABINOIDES; ANSIOLÍTICOS
- Language: Inglês
- Imprenta:
- Publisher: Elsevier
- Publisher place: Massachusetts
- Date published: 2016
- Source:
-
ABNT
ZUARDI, Antônio Waldo et al. The anxiolytic effects of cannabidiol (CBD). Handbook of cannabis and related pathologies. Volume 1. Tradução . Massachusetts: Elsevier, 2016. . . Acesso em: 04 nov. 2024. -
APA
Zuardi, A. W., Crippa, J. A. de S., Hallak, J. E. C., Campos, A. C. de, & Guimarães, F. S. (2016). The anxiolytic effects of cannabidiol (CBD). In Handbook of cannabis and related pathologies. Volume 1. Massachusetts: Elsevier. -
NLM
Zuardi AW, Crippa JA de S, Hallak JEC, Campos AC de, Guimarães FS. The anxiolytic effects of cannabidiol (CBD). In: Handbook of cannabis and related pathologies. Volume 1. Massachusetts: Elsevier; 2016. [citado 2024 nov. 04 ] -
Vancouver
Zuardi AW, Crippa JA de S, Hallak JEC, Campos AC de, Guimarães FS. The anxiolytic effects of cannabidiol (CBD). In: Handbook of cannabis and related pathologies. Volume 1. Massachusetts: Elsevier; 2016. [citado 2024 nov. 04 ] - Translational investigation of the therapeutic potential of cannabidiol (CBD): toward a new age
- Cannabinoids modulate proliferation, differentiation, and migration signaling pathways in oligodendrocytes
- Effects of minocycline on regional cerebral blood flow in schizophrenia
- Canabidiol: possíveis aplicacões terapêuticas em psicopatologias
- A critical review of the antipsychotic effects of cannabidiol: 30 years of a translational investigation
- Dr. Raphael Mechoulam, cannabis and cannabinoids research pioneer (November 5, 1930-March 9, 2023) and his legacy for Brazilian pharmacology [Editorial]
- Cannabidiol as an adjunctive treatment for acute bipolar depression: a pilot study
- Biological bases for a possible effect of cannabidiol in Parkinson’s disease
- Is the highest density of CB1 receptors in paranoid schizophrenia a correlate of endocannabinoid system functioning?
- Possible therapeutic uses of cannabidiol in anxiety disorders and schizophrenia
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
